Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02308527
Title Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON)
Acronym BEACON
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Birmingham
Indications
Therapies
Age Groups: child | adult
Covered Countries NLD | ITA | IRL | GBR | FRA | ESP | DNK | CHE | BEL | AUT

Facility Status City State Zip Country Details
St Anna Children's Hospital and CCRI/Studies and Statistics Vienna A-1090 Austria Details
University Hospital Gent Belgium Details
University Hospital Rigshospitalet Copenhagen DK-2100 Denmark Details
Hopital des Enfants Toulouse 31059 France Details
Our Ladys Children's Hospital Dublin Dublin Dublin 12 Ireland Details
Ospedale Pediatrico Bambino Gseu Rome 00165 Italy Details
Natasha van Eijkelenburg Utrecht Netherlands Details
Instituto de Investigacion Sanitaria Valencia 46026 Spain Details
Swiss Paediatric Oncology Group Bern 3008 Switzerland Details
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field